Search Results - "Rose, Lynda"

Refine Results
  1. 1

    Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents by Ridker, Paul M, Mora, Samia, Rose, Lynda

    Published in European heart journal (01-05-2016)
    “…Current statin guidelines in Europe and Canada advocate achieving a fixed LDL target or the attainment of a ≥50% reduction in low-density lipoprotein…”
    Get full text
    Journal Article
  2. 2

    Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy by Pradhan, Aruna D, Aday, Aaron W, Rose, Lynda M, Ridker, Paul M

    Published in Circulation (New York, N.Y.) (10-07-2018)
    “…BACKGROUND:The combination of statin therapy and PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibition markedly lowers low-density lipoprotein…”
    Get full text
    Journal Article
  3. 3

    The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials by Adamstein, Nicholas H, MacFadyen, Jean G, Rose, Lynda M, Glynn, Robert J, Dey, Amit K, Libby, Peter, Tabas, Ira A, Mehta, Nehal N, Ridker, Paul M

    Published in European heart journal (01-03-2021)
    “…The neutrophil-lymphocyte ratio (NLR) is a readily available inflammatory biomarker that may associate with atherosclerosis and predict cardiovascular (CV)…”
    Get full text
    Journal Article
  4. 4

    Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events by Ridker, Paul M, Rifai, Nader, Bradwin, Gary, Rose, Lynda

    Published in European heart journal (07-02-2016)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein that enhances degradation of the LDL receptor. While agents that inhibit PCSK9…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    C-Reactive Protein Levels and Outcomes after Statin Therapy by Ridker, Paul M, Cannon, Christopher P, Morrow, David, Rifai, Nader, Rose, Lynda M, McCabe, Carolyn H, Pfeffer, Marc A, Braunwald, Eugene

    Published in The New England journal of medicine (06-01-2005)
    “…Statin therapy lowers not only low-density lipoprotein (LDL) cholesterol levels, but also levels of C-reactive protein (CRP), a marker of inflammation. This…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Novel locus including FGF21 is associated with dietary macronutrient intake by Chu, Audrey Y, Workalemahu, Tsegaselassie, Paynter, Nina P, Rose, Lynda M, Giulianini, Franco, Tanaka, Toshiko, Ngwa, Julius S, Qi, Qibin, Curhan, Gary C, Rimm, Eric B, Hunter, David J, Pasquale, Louis R, Ridker, Paul M, Hu, Frank B, Chasman, Daniel I, Qi, Lu

    Published in Human molecular genetics (01-05-2013)
    “…Dietary intake of macronutrients (carbohydrate, protein, and fat) has been associated with risk of chronic conditions such as obesity and diabetes. Family…”
    Get full text
    Journal Article
  10. 10

    Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events by Ridker, Paul M, Rifai, Nader, Rose, Lynda, Buring, Julie E, Cook, Nancy R

    Published in The New England journal of medicine (14-11-2002)
    “…Studies have suggested that C-reactive protein, a marker of inflammation, may predict the risk of cardiovascular events, including coronary events. In this…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    A Proposal to Incorporate Trial Data Into a Hybrid ACC/AHA Algorithm for the Allocation of Statin Therapy in Primary Prevention by Ridker, Paul M, MD, MPH, Rose, Lynda, BS, Cook, Nancy R., ScD

    “…Abstract Current algorithms for statin allocation in primary prevention use epidemiologic estimates of absolute risk. However, a global risk prediction score…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Prospective study of sudden cardiac death among women in the United States by ALBERT, Christine M, CHAE, Claudia U, GRODSTEIN, Francine, ROSE, Lynda M, REXRODE, Kathryn M, RUSKIN, Jeremy N, STAMPFER, Meir J, MANSON, Joann E

    Published in Circulation (New York, N.Y.) (29-04-2003)
    “…There are few data regarding the determinants of sudden cardiac death (SCD) in women, primarily because of their markedly lower rate of SCD compared with men…”
    Get full text
    Journal Article
  20. 20

    Plasma Levels of the Proinflammatory Chitin‐Binding Glycoprotein YKL‐40, Variation in the Chitinase 3‐Like 1 Gene (CHI3L1), and Incident Cardiovascular Events by Ridker, Paul M, Chasman, Daniel I., Rose, Lynda, Loscalzo, Joseph, Elias, Jack A.

    Published in Journal of the American Heart Association (23-06-2014)
    “…Background YKL‐40, encoded by the chitinase 3‐like 1 (CHI3L1) gene, is a chitinase‐like protein involved in innate immune function hypothesized to play a role…”
    Get full text
    Journal Article